Director, Master of Science in Biomedical and Translational Science (MS-BATS) Program

The University of California, Irvine (UCI) Institute for Clinical and Translational Sciences (ICTS) and the School of Medicine announces a national search led by Grant Cooper for the Director of the Master of Science in Biomedical and Translational Science (MS-BATS) program. UCI is ranked 10th best public university in the nation and 33rd among all American universities, public and private, according to the annual U.S. News & World Report "America's Best Colleges" 2022 survey. For the 22nd consecutive year, U.S. News & World Report has recognized UCI Medical Center as one of America's Best Hospitals and the School of Medicine is ranked 44th overall by the U.S. News & World Report "Best Medical Schools for Research". The Institute for Clinical and Translational Science, one of 60 CTSAs around the country, has been continuously funded by the NIH since 2010 and has the mission of advancing clinical and translational sciences to drive the next generation of discoveries that will directly impact patient care.

The MS-BATS program, created in 2012, has successfully trained translational scientists and industry leaders to conduct clinical research that translates biomedical discoveries into clinical practice. The new director will be expected to continue this tradition by leading and growing an education and training program that will develop the next generation of leaders. This program involves a mixture of asynchronous and synchronous learning activities and focused research development activities designed to accommodate faculty, medical students, residents, and working professionals. The director will also have direct input into advancing a faculty development pipeline from the diverse undergraduates, medical students, and residents at UC Irvine in addition to providing educational opportunities for those interested in matriculating in the program who are not currently part of other UC Irvine programs. The overall goal is to develop the next generation of NIH-funded translational scientists or industry leaders who are armed with a unique set of interdisciplinary skills that they acquired through the program.

Our search will identify outstanding candidates with administrative and academic leadership and interdisciplinary training experience. Candidates should be distinguished scholars and translational scientists, and forward-thinking leaders who have a vision for developing the next generation of translational-scientist leaders. Candidates would be expected to have a distinguished record of achievement in research, a strong track record of mentorship, experience in developing educational programs, experience in administration, and a track record in team science.

We desire applicants who have evidence of commitment to or strong potential for commitment to the advancement of diversity, equity, and inclusion for underrepresented minority students and groups (Black/African-American, Latino(a)/Chicano(a)/Hispanic, and Native American). UCI is a Minority Serving Institution (MSI), a Hispanic-Serving Institution (HSI) and an Asian American and Native American Pacific Islander-Serving Institution (AANAPISI). These federal designations align with UCI's aspiration to be a national leader and global model of inclusive excellence. We seek faculty who are committed to diversity as well as diverse faculty who will be role models for our students.

Eligibility:

* An MD, DO, PhD, or MD/PhD (or equivalent).

* Be eligible for appointment as an associate or full professor.

* Demonstrated record of scholarly productivity, significant history of independent NIH funding, and involvement in academic societies at a national level.

* Experience in developing transdisciplinary education programs.

* History of mentoring candidates to obtain NIH career development awards.

* Proven track-record of high-quality translational science and clinically relevant research.

* Proven ability to work in a collaborative environment with other units involved in clinical research.

This position is being recruited in the following faculty titles, designation into the following title series will be dependent upon qualifications: Tenured Professor of Line series.

Criteria for the Ladder Rank Series:

Ladder-Rank Faculty will serve as research scholars, clinicians, and educators. They are expected to design and lead significant, thematic research with extramural support. Teaching is required and may include clinical, classroom or lab teaching. Faculty will also take part in campus and professional service.

The base salary range for the rank position is $135,044 to $486,546.00. The posted UC salary scales set the minimum pay determined by rank and/or step at appointment. See Professorial Series (Adjunct, Clinical X, HS Clinical, In Residence, Ladder Rank) and Professor of Teaching Series - Health Sciences Compensation Plan . This position includes membership in the health sciences compensation plan, which provides for eligibility for additional compensation.

Initial application materials should include a curriculum vitae, a one-page letter of interest, and a separate statement that addresses past and potential contributions to diversity, equity and inclusion. Applicants must complete an online application profile and upload their CV and application materials electronically for full consideration.

Application review will begin immediately and continue until the position has been filled.

As a condition of employment, you will be required to comply with the University of California Policy on Vaccination Programs - With Updated Interim Amendments. All Covered Individuals under the policy must provide proof of receiving the COVID-19 Vaccine Primary Series or, if applicable, submit a request for Exception (based on Medical Exemption, Disability, Religious Objection, and/or Deferral based on pregnancy or recent COVID-19 diagnosis and/or treatment) no later than the applicable deadline. All Covered Individuals must also provide proof of receiving the most recent CDC-recommended COVID-19 booster or properly decline such booster no later than the applicable deadline. New University of California employees should refer to Exhibit 2, Section II.C. of the SARS-CoV-2 (COVID-19) Vaccination Program Attachment for applicable deadlines. All Covered Individuals must also provide proof of being up-to-date on seasonal influenza vaccination or properly decline such vaccination no later than the applicable deadline. Please refer to the Seasonal Influenza Vaccination Program Attachment. (Capitalized terms in this paragraph are defined in the policy.) Federal, state, or local public health directives may impose additional requirements

• An MD, DO, PhD, or MD/PhD (or equivalent).

• 3 required (contact information only)

The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC anti-discrimination policy.

As a University employee, you will be required to comply with all applicable University policies and/or collective bargaining agreements, as may be amended from time to time. Federal, state, or local government directives may impose additional requirements.